thromboembolic pulmonary hypertension

Bayer wins key FDA approval for lung disease drug Adempas
Fierce Biotech
Wed, 10/9/13 - 10:13 am
Adempas
Bayer
FDA
Riociguat
thromboembolic pulmonary hypertension